Experimental COVID-19 drug reduced hospitalizations and deaths by half, Merck says

Most COVID-19 treatments currently available are largely ineffective but a pharmaceutical giant says its new pill could cut severe illness and death from the virus in half.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting